Investors bet on AI drug discovery despite approval gap

Dimension Capital, a US specialist venture firm, has raised an $800mn fund to back AI-designed medicines, signaling continued investor confidence in AI drug discovery despite no AI-discovered drugs having received regulatory approval yet.

Investors bet on AI drug discovery despite approval gap Source: Financial Times Technology https://www.ft.com/technology US specialist venture firm Dimension Capital raises $800mn fund to back AI-designed medicines Get AI news in your inbox Daily digest of what matters in AI. Get AI news in your inbox Daily digest of what matters in AI.